Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Early Diagnosis Of Chemotherapy-induced Cardiotoxicity By Cardiac MRI.

Riccardo Cau, Pierpaolo Bassareo, V. Cherchi, V. Palmisano, J. S. Suri, M. Porcu, A. Balestrieri, G. Pontone, L. Saba
Published 2020 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Survival rate in cancer patients has improved over the course of the years. In cancer survivors, cardiovascular disease is the second leading cause of mortality and early detection and serial monitoring of cardiotoxicity are key factors towards the improvement of patients' outcomes. This review article will provide an overview of the existing literature regarding the tools that MRI can offer in the early diagnosis of myocardial damage.
This paper references
10.1016/j.jacc.2010.11.013
Assessment of myocardial fibrosis with cardiovascular magnetic resonance.
N. Mewton (2011)
10.1186/s12968-018-0516-1
Automated analysis of cardiovascular magnetic resonance myocardial native T1 mapping images using fully convolutional neural networks
A. S. Fahmy (2019)
10.1016/j.amjcard.2014.07.051
Relation of strain by feature tracking and clinical outcome in children, adolescents, and young adults with hypertrophic cardiomyopathy.
Brandon M. Smith (2014)
10.1007/s12350-018-1293-9
Cardiac MRI for the evaluation of oncologic cardiotoxicity
A. I. Löffler (2018)
10.1016/j.pbiomolbio.2016.06.001
Mapping cardiac microstructure of rabbit heart in different mechanical states by high resolution diffusion tensor imaging: A proof-of-principle study
I. Teh (2016)
10.1148/RADIOLOGY.169.1.3420283
Human heart: tagging with MR imaging--a method for noninvasive assessment of myocardial motion.
E. Zerhouni (1988)
10.1016/j.jcmg.2013.05.005
Advances in parametric mapping with CMR imaging.
M. Salerno (2013)
10.1016/0002-9343(78)90802-1
Early anthracycline cardiotoxicity.
M. Bristow (1978)
10.1186/1478-4491-11-19
Ten principles of good interdisciplinary team work
S. Nancarrow (2013)
10.5603/KP.2016.0141
[2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure].
P. Ponikowski (2016)
10.1016/j.jcmg.2017.04.006
Native T1 Mapping and Extracellular Volume Mapping for the Assessment of Diffuse Myocardial Fibrosis in Dilated Cardiomyopathy.
S. Nakamori (2018)
10.1186/s12968-019-0575-y
Machine learning in cardiovascular magnetic resonance: basic concepts and applications
T. Leiner (2019)
10.1038/s41598-019-47775-4
Myocardial strain assessed by feature tracking cardiac magnetic resonance in patients with a variety of cardiovascular diseases – A comparison with echocardiography
K. Pryds (2019)
10.1016/j.amjcard.2012.07.040
Left ventricular mass in patients with a cardiomyopathy after treatment with anthracyclines.
T. Neilan (2012)
10.1016/j.jcmg.2015.11.001
Tissue Tracking Technology for Assessing Cardiac Mechanics: Principles, Normal Values, and Clinical Applications.
P. Claus (2015)
10.1038/s41598-017-02627-x
Early Detection and Serial Monitoring of Anthracycline-Induced Cardiotoxicity Using T1-mapping Cardiac Magnetic Resonance Imaging: An Animal Study
Y. J. Hong (2017)
10.1016/j.ijcard.2016.06.095
Focal fibrosis and diffuse fibrosis are predictors of reversed left ventricular remodeling in patients with non-ischemic cardiomyopathy.
T. Yingchoncharoen (2016)
10.1016/j.ijcha.2015.11.004
Doxorubicin induced heart failure: Phenotype and molecular mechanisms
M. Mitry (2016)
10.1016/j.jacc.2018.03.521
Artificial Intelligence in Cardiology.
K. Johnson (2018)
10.1016/j.jcmg.2012.11.017
Low to moderate dose anthracycline-based chemotherapy is associated with early noninvasive imaging evidence of subclinical cardiovascular disease.
Brandon C. Drafts (2013)
10.1016/j.jacc.2018.11.046
Serial Magnetic Resonance Imaging to Identify Early Stages of Anthracycline-Induced Cardiotoxicity.
Carlos Galán‐Arriola (2019)
10.1016/j.jacc.2009.02.050
Cardiovascular complications of cancer therapy: incidence, pathogenesis, diagnosis, and management.
E. T. Yeh (2009)
10.1093/ehjci/jeu181
Assessment of myocardial deformation with cardiac magnetic resonance strain imaging improves risk stratification in patients with dilated cardiomyopathy.
S. Buß (2015)
10.1161/CIRCIMAGING.115.004325
Anthracycline-Associated T1 Mapping Characteristics Are Elevated Independent of the Presence of Cardiovascular Comorbidities in Cancer Survivors
J. Jordan (2016)
10.1016/S0195-668X(03)00347-6
European guidelines on cardiovascular disease prevention in clinical practice: third joint task force of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by invited experts).
G. D. De Backer (2003)
10.1016/J.EJRAD.2019.02.038
The present and future of deep learning in radiology.
L. Saba (2019)
10.1016/j.jcmg.2018.06.004
Cardiovascular Magnetic Resonance in the Oncology Patient
J. Jordan (2018)
10.1186/1532-429X-15-8
Global and regional left ventricular myocardial deformation measures by magnetic resonance feature tracking in healthy volunteers: comparison with tagging and relevance of gender
D. Augustine (2013)
10.1016/j.jcmg.2018.04.030
Automated Cardiac MR Scar Quantification in Hypertrophic Cardiomyopathy Using Deep Convolutional Neural Networks.
A. Fahmy (2018)
10.1007/s12350-012-9512-2
Non-invasive imaging and monitoring cardiotoxicity of cancer therapeutic drugs
R. Jiji (2012)
10.1016/j.echo.2013.11.014
Myocardial deformation imaging by two-dimensional speckle-tracking echocardiography for prediction of global and segmental functional changes after acute myocardial infarction: a comparison with late gadolinium enhancement cardiac magnetic resonance.
E. Altiok (2014)
10.1016/j.atherosclerosis.2019.12.001
Performance of a deep learning algorithm for the evaluation of CAD-RADS classification with CCTA.
G. Muscogiuri (2019)
10.1161/CIR.0b013e3181d44a8f
ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents.
W. Hundley (2010)
10.1186/s12968-017-0350-x
Abnormal T2 mapping cardiovascular magnetic resonance correlates with adverse clinical outcome in patients with suspected acute myocarditis
M. Spieker (2017)
10.1002/ehf2.12277
Native myocardial T1 time can predict development of subsequent anthracycline‐induced cardiomyopathy
F. Muehlberg (2018)
10.1186/s12968-015-0214-1
Contrast-free detection of myocardial fibrosis in hypertrophic cardiomyopathy patients with diffusion-weighted cardiovascular magnetic resonance
C. Nguyen (2015)
10.1161/CIRCIMAGING.111.967836
Improved Detection of Myocardial Involvement in Acute Inflammatory Cardiomyopathies Using T2 Mapping
P. Thavendiranathan (2012)
10.1038/s41598-019-39807-w
Feature-tracking myocardial strain in healthy adults- a magnetic resonance study at 3.0 tesla
K. Mangion (2019)
10.1007/s10741-017-9621-8
Strain imaging using cardiac magnetic resonance
A. Scatteia (2017)
10.1056/NEJM200011163432003
The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction.
R. Kim (2000)
10.1016/j.carpath.2009.07.004
Pathology of late-onset anthracycline cardiomyopathy.
Bob N Bernaba (2010)
10.1002/ejhf.654
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
J. Zamorano (2017)
10.1001/jamacardio.2016.3841
A Population-Based Study of Cardiovascular Mortality Following Early-Stage Breast Cancer
H. Abdel-Qadir (2017)
10.1006/JMRE.1998.1676
DENSE: displacement encoding with stimulated echoes in cardiac functional MRI.
A. Aletras (1999)
10.1161/CIRCULATIONAHA.109.930636
Equilibrium Contrast Cardiovascular Magnetic Resonance for the Measurement of Diffuse Myocardial Fibrosis: Preliminary Validation in Humans
A. Flett (2010)
10.1016/j.jacc.2013.01.019
Cardiac magnetic resonance imaging in the evaluation of the late effects of anthracyclines among long-term survivors of childhood cancer.
Kaisa Ylänen (2013)
10.1016/j.jcmg.2015.02.005
The Combined Incremental Prognostic Value of LVEF, Late Gadolinium Enhancement, and Global Circumferential Strain Assessed by CMR.
I. Mordi (2015)
10.1016/j.echo.2014.07.012
Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.
J. Plana (2014)
10.1109/TMI.2018.2837502
Deep Learning Techniques for Automatic MRI Cardiac Multi-Structures Segmentation and Diagnosis: Is the Problem Solved?
O. Bernard (2018)
10.1148/rg.325115098
Myocardial tagging with MR imaging: overview of normal and pathologic findings.
M. Jeung (2012)
10.1016/0002-9343(87)90212-9
Congestive heart failure and left ventricular dysfunction complicating doxorubicin therapy. Seven-year experience using serial radionuclide angiocardiography.
R. G. Schwartz (1987)
10.15420/ecr.2017:17:2
Cardio-oncology: A Focus on Cardiotoxicity.
A. Koutsoukis (2018)
10.1186/s12968-015-0199-9
Fast T2 gradient-spin-echo (T2-GraSE) mapping for myocardial edema quantification: first in vivo validation in a porcine model of ischemia/reperfusion
R. Fernández‐Jiménez (2015)
10.1136/bmj.b4606
Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort
D. Mulrooney (2009)
10.1186/1532-429X-15-48
Diffuse myocardial fibrosis by T1-mapping in children with subclinical anthracycline cardiotoxicity: relationship to exercise capacity, cumulative dose and remodeling
E. Tham (2013)
10.1002/mrm.1195
Imaging longitudinal cardiac strain on short‐axis images using strain‐encoded MRI
N. Osman (2001)
10.1200/JCO.2005.05.827
Type II chemotherapy-related cardiac dysfunction: time to recognize a new entity.
M. Ewer (2005)
10.1007/s00059-007-2972-5
Significance of Late Gadolinium Enhancement in Cardiovascular Magnetic Resonance Imaging (CMR)
M. Voehringer (2007)
10.1016/j.ijcard.2018.03.041
Myocardial strain imaging by cardiac magnetic resonance for detection of subclinical myocardial dysfunction in breast cancer patients receiving trastuzumab and chemotherapy.
G. Ong (2018)
10.1093/ANNONC/MDS293
Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO Clinical Practice Guidelines.
G. Curigliano (2012)
10.1093/ehjci/jex159
Effect of candesartan and metoprolol on myocardial tissue composition during anthracycline treatment: the PRADA trial
S. L. Heck (2018)
10.1016/j.echo.2012.09.001
Use of echocardiography to evaluate the cardiac effects of therapies used in cancer treatment: what do we know?
L. Oreto (2012)
10.1186/1532-429X-11-56
T2 quantification for improved detection of myocardial edema
S. Giri (2009)
10.1186/1532-429X-15-92
Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement
J. Moon (2013)
10.1016/j.jacc.2015.04.059
Cardiovascular Health of Patients With Cancer and Cancer Survivors: A Roadmap to the Next Level.
A. Barac (2015)
10.1001/JAMA.1978.03290150049023
Doxorubicin cardiotoxicity. Serial endomyocardial biopsies and systolic time intervals.
M. Friedman (1978)
10.1007/s11864-019-0672-z
Advanced Imaging Modalities to Monitor for Cardiotoxicity
A. Seraphim (2019)
10.1001/jamacardio.2017.2511
Temporal Relation Between Myocardial Fibrosis and Heart Failure With Preserved Ejection Fraction: Association With Baseline Disease Severity and Subsequent Outcome
E. Schelbert (2017)
10.1177/1179546819866445
Cancer Therapy-Related Cardiac Dysfunction: An Overview for the Clinician
Irving E. Perez (2019)
10.14740/jocmr3617w
Comparison of Comorbid Conditions Between Cancer Survivors and Age-Matched Patients Without Cancer
S. Roy (2018)
10.1056/NEJMSA060185
Chronic Health Conditions in Adult Survivors of Childhood Cancer
K. Oeffinger (2006)
10.1186/1532-429X-10-5
Delayed contrast enhancement cardiac magnetic resonance imaging in trastuzumab induced cardiomyopathy
N. Fallah-Rad (2008)
10.1186/1532-429X-15-66
Understanding cardiovascular injury after treatment for cancer: an overview of current uses and future directions of cardiovascular magnetic resonance
S. Vasu (2013)
10.1016/S0002-9149(02)02381-0
Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy.
F. Grothues (2002)
10.1097/COC.0b013e31829e19be
Cardiac Magnetic Resonance Imaging for the Assessment of the Myocardium After Doxorubicin-based Chemotherapy
M. Lunning (2015)
10.1186/s12968-016-0308-4
Cardiac T1 Mapping and Extracellular Volume (ECV) in clinical practice: a comprehensive review
P. Haaf (2016)
10.1016/j.pbiomolbio.2014.08.002
Interrogation of living myocardium in multiple static deformation states with diffusion tensor and diffusion spectrum imaging
M. Lohezic (2014)
10.1100/2012/194069
T2-Weighted Cardiac Magnetic Resonance Imaging of Edema in Myocardial Diseases
Y. Amano (2012)
10.1186/s12968-019-0559-y
Echocardiography and cardiovascular magnetic resonance based evaluation of myocardial strain and relationship with late gadolinium enhancement
J. Erley (2019)
10.1016/j.ijcard.2016.02.137
Cost-effectiveness of strain-targeted cardioprotection for prevention of chemotherapy-induced cardiotoxicity.
M. Nolan (2016)
10.1016/j.cjca.2016.04.014
The Cardio-oncology Program: A Multidisciplinary Approach to the Care of Cancer Patients With Cardiovascular Disease.
Sarah J Parent (2016)
10.1093/ehjci/jev006
Myocardial strain measurement with feature-tracking cardiovascular magnetic resonance: normal values.
R. Taylor (2015)
10.1186/s12968-017-0373-3
Automated assessments of circumferential strain from cine CMR correlate with LVEF declines in cancer patients early after receipt of cardio-toxic chemotherapy
M. Jolly (2017)
10.1016/j.jcmg.2015.11.005
T1 Mapping: Basic Techniques and Clinical Applications.
A. Taylor (2016)
10.1016/j.amjcard.2012.11.022
Myocardial extracellular volume by cardiac magnetic resonance imaging in patients treated with anthracycline-based chemotherapy.
T. Neilan (2013)
10.1136/heartjnl-2015-307848
Cardiovascular biomarkers in patients with cancer and their association with all-cause mortality
N. Pavo (2015)
10.1016/j.jacc.2009.03.095
Anthracycline-induced cardiomyopathy: clinical relevance and response to pharmacologic therapy.
D. Cardinale (2010)
10.1016/j.echo.2014.11.003
Definitions for a common standard for 2D speckle tracking echocardiography: consensus document of the EACVI/ASE/Industry Task Force to standardize deformation imaging.
J. Voigt (2015)
10.1148/radiol.13121239
MR imaging of cardiac tumors and masses: a review of methods and clinical applications.
M. Motwani (2013)
10.3978/j.issn.2223-3652.2015.06.07
Cardiac MR imaging: current status and future direction.
M. Saeed (2015)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar